Item 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
See our most recently filed Annual Report on Form 10-K (Part I, Item 1A). The risks described in the Annual Report on Form 10-K, and the “Forward-Looking Statements” in this report, are not the only risks we face. Additional risks and uncertainties may also materially affect our business, financial condition, or operating results. One should not consider the risk factors to be a complete discussion of risks, uncertainties, and assumptions.
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Purchases of our common stock during the third quarter of 2024 were as follows:
| | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | Total Number of | | |||||
| | | | | | | | Shares Purchased as | | Maximum Number of | ||
| | | Total Number of | | | | | Part of Publicly | | Shares that May Yet Be | ||
| | | Shares | | | | | Announced Plans or | | Purchased under the | ||
| | | Purchased | | Average Price | | Programs (1) | | Plans or Programs (1) | |||
| Period | | (thousands) | | Per Share | | (thousands) | | (millions) | |||
| Apr 29 to May 26 | | 900 | $ | 403.24 | | 900 | | 26.3 | | | |
| May 27 to Jun 23 | | 659 | | | 375.46 | | 659 | | 25.7 | | |
| Jun 24 to Jul 28 | | 537 | | | 375.06 | | 537 | | 25.2 | | |
| Total | | 2,096 | | | | | 2,096 | | | | |
| (1) | We have a share repurchase plan that was announced in December 2022 to purchase up to $18.0 billion of shares of our common stock. The maximum number of shares that may yet be purchased under this plan was 25.2 million based on the closing price of our common stock on the New York Stock Exchange as of the end of the third quarter of 2024 of $386.55 per share. At the end of the third quarter of 2024, $9.7 billion of common stock remained to be purchased under this plan. |
|---|
Item 3.Defaults Upon Senior Securities
None.
Item 4.Mine Safety Disclosures
Not applicable.
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. Other Information